I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| goblet cell | 4 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| goblet cell | 4 studies | 26% ± 9% |
Insufficient scRNA-seq data for expression of SLC2A10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2552.41 | 245 / 245 | 99% | 67.95 | 499 / 502 |
| breast | 100% | 1951.51 | 458 / 459 | 96% | 71.91 | 1069 / 1118 |
| pancreas | 100% | 1853.33 | 328 / 328 | 93% | 29.10 | 165 / 178 |
| thymus | 100% | 2944.88 | 653 / 653 | 87% | 35.53 | 527 / 605 |
| ovary | 100% | 1368.40 | 180 / 180 | 87% | 18.74 | 373 / 430 |
| liver | 100% | 4206.65 | 226 / 226 | 81% | 23.38 | 328 / 406 |
| bladder | 100% | 1480.29 | 21 / 21 | 81% | 20.60 | 407 / 504 |
| stomach | 100% | 1455.38 | 359 / 359 | 78% | 19.71 | 224 / 286 |
| lung | 98% | 1241.20 | 565 / 578 | 76% | 19.36 | 880 / 1155 |
| intestine | 100% | 1064.05 | 964 / 966 | 70% | 16.87 | 368 / 527 |
| esophagus | 99% | 967.16 | 1424 / 1445 | 70% | 17.29 | 128 / 183 |
| uterus | 100% | 1258.75 | 170 / 170 | 60% | 16.10 | 277 / 459 |
| skin | 84% | 1955.93 | 1524 / 1809 | 67% | 20.80 | 318 / 472 |
| adrenal gland | 97% | 1055.03 | 251 / 258 | 33% | 4.49 | 76 / 230 |
| kidney | 84% | 473.36 | 75 / 89 | 45% | 7.32 | 409 / 901 |
| brain | 51% | 228.15 | 1356 / 2642 | 50% | 11.63 | 356 / 705 |
| adipose | 100% | 1298.61 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1192.93 | 1318 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 76% | 341.98 | 182 / 241 | 0% | 0 | 0 / 0 |
| heart | 71% | 465.81 | 608 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 60% | 11.79 | 48 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 29% | 4.64 | 13 / 45 |
| muscle | 10% | 40.37 | 82 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045454 | Biological process | cell redox homeostasis |
| GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO_2001045 | Biological process | negative regulation of integrin-mediated signaling pathway |
| GO_1904659 | Biological process | glucose transmembrane transport |
| GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO_0098708 | Biological process | glucose import across plasma membrane |
| GO_0010629 | Biological process | negative regulation of gene expression |
| GO_0150104 | Biological process | transport across blood-brain barrier |
| GO_0015757 | Biological process | galactose transmembrane transport |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0072498 | Biological process | embryonic skeletal joint development |
| GO_0032683 | Biological process | negative regulation of connective tissue growth factor production |
| GO_0072359 | Biological process | circulatory system development |
| GO_1902729 | Biological process | negative regulation of proteoglycan biosynthetic process |
| GO_0070837 | Biological process | dehydroascorbic acid transport |
| GO_1903053 | Biological process | regulation of extracellular matrix organization |
| GO_0060840 | Biological process | artery development |
| GO_0008645 | Biological process | hexose transmembrane transport |
| GO_0043588 | Biological process | skin development |
| GO_1902730 | Biological process | positive regulation of proteoglycan biosynthetic process |
| GO_1902600 | Biological process | proton transmembrane transport |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0012505 | Cellular component | endomembrane system |
| GO_0016020 | Cellular component | membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0015293 | Molecular function | symporter activity |
| GO_0055056 | Molecular function | D-glucose transmembrane transporter activity |
| GO_0033300 | Molecular function | dehydroascorbic acid transmembrane transporter activity |
| GO_0005351 | Molecular function | carbohydrate:proton symporter activity |
| Gene name | SLC2A10 |
| Protein name | Solute carrier family 2, facilitated glucose transporter member 10 (Glucose transporter type 10) (GLUT-10) Solute carrier family 2 facilitated glucose transporter member 10 Solute carrier family 2 member 10 |
| Synonyms | GLUT10 |
| Description | FUNCTION: Facilitative glucose transporter required for the development of the cardiovascular system. . |
| Accessions | Q8TDC7 ENST00000359271.4 ENST00000486000.2 O95528 A0A087WUH5 |
